Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Conditions
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mary Greeley Medical Center, Ames, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)McFarland Clinic - Ames, Ames, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)McFarland Clinic - Boone, Boone, Iowa, United States
McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)McFarland Clinic - Jefferson, Jefferson, Iowa, United States
McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)Tufts Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Site Public Contact) · ContactUsCancerCenter@TuftsMedicalCenter.org · 617-636-5000Contact: Principal Investigator (Raymond L. Comenzo)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Clifton C. Mo)Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States
Contact: Principal Investigator (Donald J. Jurgens)Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Commack, Commack, New York, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Westchester, Harrison, New York, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Saad Z. Usmani)OhioHealth O'Bleness Hospital, Athens, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Riverside Methodist Hospital, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Grant Medical Center, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Doctors Hospital, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Grady Memorial Hospital, Delaware, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Columbus Oncology and Hematology Associates, Dublin, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Dublin Methodist Hospital, Dublin, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Mansfield Hospital, Mansfield, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Marion General Hospital, Marion, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Pickerington Methodist Hospital, Pickerington, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Westerville Medical Campus/Westerville Cancer Center, Westerville, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Muhammad Salman Faisal)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Muhamed Baljevic)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Douglas W. Sborov)Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Ravi Kishore Narra)ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Sheboygan Physicians Group, Sheboygan, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States
Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581Contact: Principal Investigator (Adedayo A. Onitilo)Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)Marshfield Medical Center - Weston, Weston, Wisconsin, United States
Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581Contact: Principal Investigator (Adedayo A. Onitilo)